tiprankstipranks
Crinetics Pharmaceuticals (CRNX)
NASDAQ:CRNX
US Market
Holding CRNX?
Track your performance easily

Crinetics Pharmaceuticals (CRNX) Income Statement

485 Followers

Crinetics Pharmaceuticals Income Statement

Last quarter (Q3 2024), Crinetics Pharmaceuticals's total revenue was $―, a decrease of -100.00% from the same quarter last year. In Q3, Crinetics Pharmaceuticals's net income was $-76.83M. See Crinetics Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 1.04M$ 4.01M$ 4.74M$ 1.08M$ 71.00K$ 1.19M
Cost of Revenue
------
Gross Profit
$ 1.04M$ 4.01M$ 4.74M$ 1.08M$ 71.00K$ 1.19M
Operating Expense
$ 307.81M$ 226.62M$ 172.62M$ 108.78M$ 75.02M$ 55.02M
Operating Income
$ -306.77M$ -222.61M$ -167.88M$ -107.70M$ -74.95M$ -53.83M
Net Non Operating Interest Income Expense
$ 33.79M$ 13.44M$ 4.32M$ 157.00K$ 991.00K$ 3.46M
Other Income Expense
$ -3.69M$ -5.36M$ -353.00K$ 86.00M$ -150.00K$ 50.00K
Pretax Income
$ -277.50M$ -214.53M$ -163.92M$ -107.55M$ -73.81M$ -50.42M
Tax Provision
$ -797.00K$ -797.00K$ -128.00K$ -7.08M$ -4.89M$ -3.43M
Earnings From Equity Interest Net Of Tax
$ -5.67M$ -5.20M$ -1.01M---
Net Income Common Stockholders
$ -277.90M$ -214.53M$ -163.92M$ -107.64M$ -73.81M$ -50.42M
Basic EPS
$ -3.72$ -3.69$ -3.15$ -2.80$ -2.42$ -2.09
Diluted EPS
$ -3.72$ -3.69$ -3.15$ -2.80$ -2.42$ -2.09
Basic Average Shares
$ 298.68M$ 58.07M$ 51.98M$ 38.44M$ 30.45M$ 24.18M
Diluted Average Shares
$ 298.68M$ 58.07M$ 51.98M$ 38.44M$ 30.45M$ 24.18M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 307.81M$ 226.62M$ 172.62M$ 108.78M$ 75.02M$ 55.02M
Net Income From Continuing And Discontinued Operation
$ -277.91M$ -214.53M$ -163.92M$ -107.64M$ -73.81M$ -50.42M
Normalized Income
$ -149.32M-----
Interest Expense
------
EBIT
$ -287.07M$ -222.61M$ -167.88M$ -107.70M$ -74.95M$ -50.42M
EBITDA
$ -280.96M$ -221.51M$ -166.90M$ -106.78M$ -74.00M$ -50.76M
Currency in USD

Crinetics Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis